News Search Results
Dec 18, 2025, 11:00 ET Med School Dropout-Turned-CEO Woonyeon Kim's GravityLabs Secures $17M Series A, Accelerates US Market Push
Dec. 18, 2025 /PRNewswire/ -- AI-powered healthcare startup GravityLabs has successfully secured $17M USD in Series A funding and is now accelerating its entry into the US market. Led by CEO Woonyeon
More news about: GravityLabs
Dec 18, 2025, 10:16 ET From Hiring to IPOs, Crypto Startups Plan for Growth in 2026
The survey, conducted in November 2025, collected responses from founders and executives at 25 Seed and Series A-stage portfolio companies. Respondents represent a cross-section of CoinFund's portfolio companies."Crypto now has multiple real
More news about: CoinFund
Dec 18, 2025, 09:00 ET Relief Cardiovascular Appoints Harry Rowland as Chairman of the Board
hemodynamic monitoring with active preload modulation. Relief Cardiovascular was founded and incubated within inQB8 Medical Technologies, LLC. The company's Series A financing supporting its first-in-human study was co-led by Broadview Ventures and Advent Life Sciences with additional participation from Good Growth
More news about: Relief Cardiovascular
Dec 17, 2025, 16:10 ET Gloo Holdings, Inc. Reports Third Fiscal Quarter 2025 Financial Results
Series A Preferred Units (no par value; 39,250,615 authorized as of October 31, 2025 and January 31, 2025; 38,523,781 and 37,532,207 units issued
More news about: Gloo
Dec 17, 2025, 13:00 ET MARABIO LAUNCHES FIRST-EVER BLOOD TEST FOR MATERNAL AUTOANTIBODY RELATED AUTISM
biological cause of their child's autism. Those efforts have been further supported by additional investment , including $19.1 million in an initial Series A financing led by MAK Capital One LLC (MAK) with participation by Autism Impact Fund (AIF), and an additional $1.7 million in subsequent closings from
More news about: MARAbio
Dec 17, 2025, 10:00 ET PARAMOUNT AFFIRMS COMMITMENT TO SUPERIOR $30 PER SHARE ALL-CASH OFFER FOR WARNER BROS. DISCOVERY
include, among others: the outcome of the tender offer by Paramount and Prince Sub Inc. (the "Tender Offer") to purchase for cash all of the outstanding Series A common stock of WBD or any discussions between Paramount and WBD with respect to a possible transaction (including, without limitation, by means of
More news about: Paramount Skydance Corporation
Dec 17, 2025, 09:30 ET Vitalis Ventures Announces $15 Million Strategic Funding for Drive Health to Accelerate Avery, the Clinical Workflow AI
is expanding Avery's clinical workflow and operational capabilities, building toward broader health system and health plan deployment and a planned Series A in 2026. MIAMI, Dec. 17, 2025 /PRNewswire/ --
More news about: Vitalis
Dec 17, 2025, 09:09 ET Ace Pickleball Club Launches National Player Development Series to Elevate Skills for Every Level of Play
Pickleball Club (APC), a rapidly expanding national pickleball franchise, announced the nationwide launch of its new Player Development Series, a comprehensive four-stage training pathway designed to help players learn, grow, and elevate their game at every skill level.
More news about: Ace Pickleball Club
Dec 17, 2025, 09:00 ET AidKit Closes a Pivotal Year as Trusted Aid Infrastructure, Unveils New Brand Identity
accelerated its national footprint and operational maturity through a series of milestones, including:Securing $8.5 million in Series A funding to advance product development and expand client servicesLaunching AidKit Essentials, a rapid-deployment toolkit combining proven
More news about: AidKit
Dec 17, 2025, 08:39 ET SHOPLINE and Hive Analytics Announce Partnership to Deliver Full-Stack Growth for Consumer Brands
deliver full-stack growth on a platform built for global expansion."The partnership primarily supports growth-stage brands - from post-seed to Series A - as well as mature brands looking to modernize their digital strategy or expand into new markets across fashion, beauty, food and beverage, consumer
More news about: SHOPLINE
Dec 16, 2025, 19:30 ET Aussie medtech Ferronova raises another $6 million to advance image-guided cancer surgery
Venture Partners and Renew Pharmaceuticals (a subsidiary of Singapore-based Ultragreen.ai). The latest capital raising brings the total generated in Series A rounds to $17.5 million.Ferronova is currently undertaking a 60 patient, two-year trial of the technology in stomach and oesophageal cancers
More news about: Ferronova Pty. Ltd
Dec 16, 2025, 16:30 ET Fulton Financial Corporation Announces Increased Common Stock Dividend, Preferred Stock Dividend and $150 Million Repurchase Program
a quarterly dividend of $12.81 per share (equivalent to $0.32025 per depositary share) on its Fixed Rate Non-Cumulative Perpetual Preferred Stock, Series A ("Preferred Stock"), payable on January 15, 2026, to shareholders of record as of December 31, 2025, for the period from and including October 15,
More news about: Fulton Financial Corporation
Dec 16, 2025, 10:16 ET Echo Raises $50M in 10 Months to Build a Secure, AI-Native OS for Cloud Applications
The $35M Series A round comes just four months after Echo announced its $15 million seed round, bringing total funding to $50 millionNEW YORK, Dec. 16, 2025 /PRNewswire/ --
More news about: Echo Software Ltd.
Dec 16, 2025, 09:16 ET BaseLaunch Announces the Addition of Takeda as New Pharmaceutical Partner to its Biotech Venture Incubator
help launch and grow exceptional biotech ventures developing cutting-edge therapeutics. The platform helps build companies from inception through to Series A funding, providing financing and supporting all aspects of company creation and growth. It is operationally run and financed by Basel Area Business
More news about: BaseLaunch
Dec 16, 2025, 09:01 ET Molly Sims' YSE Beauty Closes $15M Series A Growth Equity Investment From Silas Capital and L Catterton
/PRNewswire/ -- YSE Beauty, the results-driven, clinically tested skincare brand by Molly Sims has announced the successful close of its $15 million Series A funding round led by investment partner Silas Capital, an emerging growth equity and venture capital firm focused on next-generation consumer brands,
More news about: YSE Beauty
Dec 16, 2025, 09:00 ET KPM Analytics Unveils the SmartChem® 800 Series, a Next-Generation Platform for High-Throughput Wet Chemistry
In answer to these challenges, KPM Analytics announces the SmartChem® 800 Series, a next-generation automated discrete analyzer designed specifically for high-volume commercial laboratories. Building on the proven SmartChem®
More news about: KPM Analytics
Dec 16, 2025, 09:00 ET KPM Analytics Unveils the SmartChem® 800 Series, a Next-Generation Platform for High-Throughput Wet Chemistry
In answer to these challenges, KPM Analytics announces the SmartChem® 800 Series, a next-generation automated discrete analyzer designed specifically for high-volume commercial laboratories. Building on the proven SmartChem®
More news about: KPM Analytics
Dec 16, 2025, 09:00 ET Adaptive Security Raises $81 Million Series B to Stop AI-Powered Cyber Threats
In April, the Company announced a $43 million Series A led by OpenAI Startup Fund and Andreessen Horowitz, making it OpenAI's first and only cybersecurity investment. The OpenAI Startup Fund later led
More news about: Adaptive Security
Dec 16, 2025, 08:30 ET Allink Biotherapeutics Completes $47M Extension Rounds of Series A to Accelerate Clinical Programs and Novel Platforms Development
The company secured $47 million through extension rounds of Series A led by Legend Capital and Meituan Long-Z Investment with strong backing from both new investors and existing supportersProceeds to advance two differentiated and highly competitive ADC
More news about: Allink Biotherapeutics
Dec 16, 2025, 08:30 ET PhaseV Closes 2025 with Record Growth, Supporting Biopharma's Shift from AI Pilots to Full-Scale Execution
Company Enters 2026 Positioned for Wide-Scale Deployment, Fueled by $50M Series A, 40+ Global Sponsors, and Measurable ROIBOSTON, Dec. 16, 2025 /PRNewswire/ --
More news about: PhaseV
Dec 16, 2025, 08:06 ET Ambros Therapeutics Launches with $125 Million Series A Financing to Advance Neridronate Through Phase 3 Registrational Program for Complex Regional Pain Syndrome Type 1
Officer leading a seasoned late-stage development team and will serve on the Board alongside Co-Founder and Chairman Keith KatkinOversubscribed Series A financing co-led by RA Capital Management and Patient Square Capital's platform Enavate Sciences with participation from a strong syndicate of dedicated
More news about: Ambros Therapeutics
Dec 16, 2025, 08:00 ET Ember LifeSciences secures $16.5 million Series A funding to advance breakthrough cold chain solutions for global healthcare
Ember LifeSciences, Inc., a leading provider of revolutionary cold chain technology, today announced a $16.5 million Series A funding round, led by Sea Court Capital, with participation from Cardinal Health, Carrier Ventures and other influential investors, including former
More news about: Ember LifeSciences
Dec 16, 2025, 02:30 ET Allink Biotherapeutics Completes $47M Extension Rounds of Series A to Accelerate Clinical Programs and Novel Platforms Development
The company secured $47 million through extension rounds of Series A led by Legend Capital and Meituan Long-Z Investment with strong backing from both new investors and existing supportersProceeds to advance two differentiated and highly competitive ADC
More news about: Allink Biotherapeutics
Dec 15, 2025, 14:00 ET MEQ Solutions lands $23m from Insight Partners to redefine how value is created in the $1 trillion global red-meat trade
MELBOURNE, Australia, Dec. 15, 2025 /PRNewswire/ -- MEQ Solutions has secured A$23 million (US $15 million) in Series A funding from global software investor Insight Partners to accelerate the rollout of its solutions and scale its mission to become the global authority
More news about: MEQ Solutions
Dec 15, 2025, 08:30 ET Link Cell Therapies Launches with Vision of Advancing CAR-T Therapies in Solid and Liquid Tumors
Closes $60 Million Series A Financing Round Backed by New and Existing Investors$92 Million Raised to Date Across Seed and Series A FinancingsSOUTH SAN FRANCISCO, Calif., Dec.
More news about: Link Cell Therapies